How to Buy Day One Biopharmaceuticals Stock
Day One Biopharmaceuticals Inc
Day One Biopharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers.
Day One Biopharmaceuticals stock last closed at $11.16, down 2.96% from the previous day, and has decreased 7.54% in one year. It has overperformed other stocks in the Biotechnology industry by 0.24 percentage points. Day One Biopharmaceuticals stock is currently +98.05% from its 52-week low of $5.64, and -15.45% from its 52-week high of $13.20.
As of Feb 3, 2026, there are 102.68M shares of DAWN outstanding. The market value of DAWN is $1.15B. In the last 24 hours, 1.9M DAWN shares were traded.
How to Buy Day One Biopharmaceuticals Stock
Wondering how to invest in Day One Biopharmaceuticals stock? Here's how.
- Decide where to buy Day One Biopharmaceuticals stock: You need to pick a stock brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you determine where to buy Day One Biopharmaceuticals stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Deposit money your investment account: Select your payment method and add your details.
- Analyze Day One Biopharmaceuticals stock: The Day One Biopharmaceuticals ticker symbol is DAWN. Is Day One Biopharmaceuticals stock a good investment? Should you buy shares of DAWN? How do DAWN's underlying business fundamentals look? Do top analysts think Day One Biopharmaceuticals is a good buy? Why has DAWN's stock price moved recently? (Hint: Our stock market research tools can help you evaluate if DAWN is a good stock to buy).
- Place your DAWN trade: Decide if you will purchase DAWN shares at the current market price or use a limit order to purchase DAWN shares at a specific price.
- Monitor your investment in DAWN: Create a watchlist to important updates regarding your investment in Day One Biopharmaceuticals shares.
Step 1: Decide where to buy Day One Biopharmaceuticals stock
You need a brokerage account in order to access the NASDAQ market and buy DAWN stock.
Our favorite brokerage: eToro
In our opinion, eToro is the best online stock brokerage. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world financial markets: From Technology to Healthcare, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've selected your brokerage, you'll need to fill out some personal details so you are able to invest in DAWN today.
How to Set Up a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to create a new brokerage account.
- Submit your information by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you've opened your account on the highest rated stock app, you can securely and quickly fund your account:
Watch the tutorial below to see the process of depositing money into your new brokerage account.
Step 4: Analyze Day One Biopharmaceuticals stock
After you have chosen the best place to buy Day One Biopharmaceuticals stock, it's important to research their stock before you invest, so you truly understand the risk as well as the upside.
Day One Biopharmaceuticals quick stats
Day One Biopharmaceuticals Fundamentals
WallStreetZen was created to help part-time investors perform more accurate fundamental analysis quickly.
You can see all of the due diligence checks on DAWN's stock page.
Is DAWN stock undervalued?
Analysts use many financial metrics, analyses, models, and charts to gauge DAWN's fair value.
Using relative valuations measures:
- DAWN may be undervalued based on its P/B ratio of 2.54x, relative to Biotechnology industry P/B ratio of 5.26x
You can do more valuation analysis on DAWN's stock here.
DAWN Financial Summary
Positive Financial Indicators:
- DAWN has cash burn of 121323000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the DAWN balance sheet.
- DAWN has $451.58M in cash and short term investments. This is sufficient to cover its annual cash burn of $121.32M.
- DAWN has a low debt to equity ratio of 0.14.
- There are more short-term assets than long-term liabilities on the DAWN balance sheet.
Negative Financial Indicators:
- DAWN profit margin has gone down from -82.7% to -113.5% in the past year.
Is it a good time to buy Day One Biopharmaceuticals stock, according to Wall Street analysts?
Out of 6 sell side analysts who track DAWN, the consensus analyst rating on DAWN is a Strong Buy
Please keep in mind that analyst ratings are not stock recommendations, nor are they investment advice.
Most Recent DAWN Analyst Upgrades/Downgrades
Andrew S. Fein, a top 12% analyst from HC Wainwright & Co. maintains DAWN with a buy rating and lowers their DAWN price target from $36.00 to $25.00, on Aug 6, 2025.
You can dive deeper into what analysts are saying on the Day One Biopharmaceuticals stock forecast page.
DAWN Trading Indicators
DAWN Performance Numbers
Last year, DAWN revenue was $133.67M. Over the last 1 years, DAWN's revenue has grown by 31.11% per year. This was slower than the Biotechnology industry average of 43.37%.
Learn more about DAWN's earnings and revenue performance here.
What are DAWN executives and large shareholders up to?
In the past year, executives and large shareholders at DAWN have sold more shares than they have bought.
Jeremy Bender, CHIEF EXECUTIVE OFFICER of DAWN, was the latest DAWN insider to sell. They sold $141,695.01 worth of DAWN shares on Nov 17, 2025.
Learn more about who owns DAWN shares here.
Does DAWN provide a stable income stream?
No, Day One Biopharmaceuticals doesn't provide an income stream by paying out dividends.
What others are saying about DAWN
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Place your DAWN trade
There are two primary order types:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are mostly sufficient. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a given dollar amount limit, place a limit order.
Hit the Open Trade button and your broker will place your order.
If you require additional help buying stocks on eToro, watch the how to video below:
Step 6: Monitor your investment in DAWN
Now that you own some DAWN shares, you'll want to stay up-to-date on your new investment.
Create a watchlist to see the latest developments about your DAWN stock.
DAWN Feed
How to Buy Stock in Day One Biopharmaceuticals
To reiterate, here are the 6 steps to buy stock in Day One Biopharmaceuticals:
- Decide where to buy Day One Biopharmaceuticals stock
- Open your brokerage account
- Deposit money your investment account
- Analyze Day One Biopharmaceuticals stock
- Place your DAWN trade
- Monitor your investment in DAWN
If you require a place to buy stocks, eToro is our recommended option.
Get Started with eToro TodayIf you want to watch your new investment in Day One Biopharmaceuticals, get started below.
Trending "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.